DNA Patents and Human Dignity

In this essay, I will use the phrase “human DNA patenting” instead of the more popular phrase “human gene patenting” because the more popular idiom is misleading. The patents that have been approved by patent offices do not mention “human genes,” but usually describe “isolated and purified DNA sequences.” This is not a trivial point: A gene is a functional unit that carries the information needed to make a protein, which includes DNA that codes for the primary structure of the protein (the coding region) as well as DNA that regulates translation and transcription of the coding region. Moreover, some DNA sequences, such as genetic markers, are much smaller than genes. Some patents, such as patents on expressed sequence tags (ESTs), apply to genetic markers. See Wong D. , The ABCs of Gene Cloning (New York: Chapman and Hall, 1997).

I would also like to point out that the notion of “human” DNA is a bit ambiguous since human beings share a large percentage of their DNA with chimpanzees, a slightly lesser percentage with pigs, and a still fair percentage with yeast. To make sense of this biological fact, by “human” DNA, I mean “DNA that is a part of a genome of a member of the species Homo sapiens.” Although much of the DNA in human DNA is structurally similar to DNA that occurs in non-human species, DNA is “human” by virtue of its functional role in a human genome. By way of comparison, the same automotive part, such as a fan belt, may be present in many different vehicles, but a fan belt is a Ford Ranger fan belt by virtue of its functional role (turning the fan) in a Ford Ranger truck. See Resnik D. , “The Morality of Human Gene Patents,” Kennedy Institute of Ethics Journal, 7, no. 1 (1997): 43–61.

Resnik D. , “The Human Genome Project: Ethical Problems and Solutions,” Politics and the Life Sciences, 18, no. 1 (1999): 15–23.

Joint Appeal Against Human and Animal Patenting, Press Conference Text (Washington, D.C.: Board of Church and Society of the United Methodist Church, May, 16, 1995).

Rifkin J. , The Biotech Century (New York: Penguin Putnam, 1998).

European Commission, Opinions of the Group of Advisors on the Ethical Implications of Biotechnology of the European Commission (Brussels: European Commission, 1996).

Knoppers M. , “Status, Sale, and Patenting of Human Genetic Material: An International Survey,” Nature Genetics, 22 (1999): 23–26.

Crespi R. , “An Analysis of Moral Issues Affecting Patenting Inventions in the Life Sciences: A European Perspective,” Science and Engineering Ethics, 6, no. 2 (2000): 157–80.

Council for Responsible Genetics, The Genetic Bill of Rights (Cambridge, Massachusetts: Council for Responsible Genetics, 2000).

Nader R. , Nader 2000 (visited November 6, 2000) <http://www.votenader.org/issues/agriculture_policy.html>.

Evans J. , “The Uneven Playing Field in the Dialogue on Patenting,” in Chapman A. , ed., Perspectives on Gene Patenting (Washington, D.C.: American Association for the Advancement of Science, 1998): At 57–74.

United States Constitution, Article 1, Section 8, Clause 8 (1787).

Patent and Trademark Office, General Information Concerning Patents (Washington, D.C.: Patent and Trademark Office, 1999).

Foster F. Shook R. , Patents, Copyrights, and Trademarks, 2d ed. (New York: John Wiley and Sons, 1993).

Diamond v. Chakrabarty, 447 U.S. 303 (1980).

Foster Shook , supra note 13.

Patent and Trademark Office, supra note 12.

Patent and Trademark Office, supra note 12.

Foster Shook , supra note 13.

Doll J. , “The Patenting of DNA,” Science, 280 (1998):689–90.

Diamond v. Chakrabarty, 447 U.S. 303 (1980).

Einsenberg R. , “Patenting the Human Genome,” Emory Law Journal, 39 (1990): 721–45;.

Eisenberg R. , “Patenting Organisms,” Encyclopedia of Bioethics, rev. ed. (New York: Simon and Schuster, 1995): At 1911–14.

Eisenberg R. , “Structure and Function in Gene Patenting,” Nature Genetics, 15, no. 2 (1997): 125–30.

The Biotechnology Industry Organization, Primer: Genetic Research, Patent Protection and 21st Century Medicine (Washington, D.C.: Biotechnology Industry Organization, 2000).

Eisenberg , supra note 22.

Sagoff M. , “DNA Patents: Making Ends Meet,” in Chapman A. , ed., Perspectives on Gene Patenting (Washington, D.C.: American Association of the Advancement of Science, 1999): At 245–68.

Wong , supra note 1.

Attwood T. , “The Babel of Bioinformatics,” Science, 290 (2000): 471–73.

Doll , supra note 19.

Merz J. , “Disease Gene Patenting Is Bad Innovation,” Molecular Diagnosis, 2, no. 4 (1997): 299–304.

Resnik D. , “DNA Patents and Scientific Discovery and Innovation: Assessing Benefits and Risks,” Science and Engineering Ethics (forthcoming).

Land R. Mitchell B. , “Patenting Life: No,” First Things, 63, (May 1997): 20–22.

Frankena W. , Ethics, 2d ed. (Englewood Cliffs, New Jersey: Prentice-Hall, 1973).

Kant I. , Groundwork of the Metaphysics of Morals, trans. Patton H. (New York: Harper Torchbooks, 1953).

Hill T. , Dignity and Practical Reason in Kant's Moral Theory (Ithaca, New York: Cornell University Press, 1992);.

Beauchamp T. Childress J. , Principles of Biomedical Ethics, 4th ed. (New York: Oxford University Press, 1996).

Steinbock B. , Life Before Birth (New York: Oxford University Press, 1992).

Ganeri A. , Religions Explained (New York: Henry Holt and Company, 1997).

Peters T. , Playing God (New York: Routledge, 1997).

Brunner E. , The Divine Imperative (Philadelphia: Westminster Press, 1947).

Gold E. , Body Parts (Washington, D.C.: Georgetown University Press, 1997).

Radin M. , Contested Commodities (Cambridge, Massachusetts: Harvard University Press, 1996).

Hanson M. , “Biotechnology and Commodification within Health Care,” Journal of Medicine and Philosophy, 24, no. 3 (1999):267–87.

Radin , supra note 40.

Hanson M. , “Religious Voices in Biotechnology: The Case of Gene Patenting,” Hastings Center Report, 27, no. 6, special supplement (1997): 1–21.

Berger F. , “Pornography, Sex, and Censorship,” Social Theory and Practice, 4, no. 2 (1997): 380–95.

Feinberg J. , Social Philosophy (Englewood Cliffs, New Jersey: Prentice-Hall, 1973).

Radin , supra note 40.

Council on Ethical and Judicial Affairs, American Medical Association, Patenting the Human Genome (Chicago: American Medical Association, 1997).

Doll J. , personal communication, September 1, 2000.

Hanson , supra note 43.

Resnik , supra note 1.

Resnik , supra note 30.

Gibbons A. , “Which of Our Genes Make Us Human?,” Science, 281 (1998): 1432–34.

Resnik , supra note 30.

Council and Ethical and Judicial Affairs, supra note 47.

Brody B. , “Protecting Human Dignity and the Patenting of Human Genes,” in Chapman A. , ed., Perspectives on Gene Patenting (Washington, D.C.: American Association of the Advancement of Science, 1999): At 111–26.

Nelkin D. Lindee S. , The DNA Mystique (New York: Free Press, 1995).

Land Mitchell , supra note 31.

Peters , supra note 37.

Brody , supra note 55.

Friedman T. , “Overcoming the Obstacles to Gene Therapy,” Scientific American, 276, no. 6 (1997): 66–101.

Brody , supra note 55.

European Commission, supra note 5.

Resnik D. Steinkraus H. Langer P. , Human Germline Gene Therapy (Austin, Texas: R.G. Landes, 1999).

Brody , supra note 55.

Nelkin D. Andrews L. , “Homo Economicus: The Commercialization of Body Tissue in the Age of Biotechnology,” Hastings Center Report, 28, no. 5 (1998): 30–39.

Resnik , supra note 30.

Radin , supra note 40;.

Nelkin Andrews , supra note 65;.

Gold , supra note 39;.

Hanson supra note 41.

Nelkin Andrews , supra note 65.

Moore v. Regents of the University of California, 793 P.2d 479 (Cal. 1990).

Hanson , supra note 41.

Feinberg , supra note 45.

Resnik , supra note 30.

Andrews L. , “Surrogate Motherhood: The Challenge for Feminists,” Law, Medicine, & Healthcare, 16, no. 1 (1988):72–80.

Anderson E. , “Is Women's Labor a Commodity?,” Philosophy and Public Affairs, 19, no. 1 (1990): 71–92.

Robertson J. , Children of Choice (Princeton: Princeton University Press, 1994).

Resnik D. , “Regulating the Market for Human Eggs,” Bioethics (forthcoming).

Hanson , supra note 43;.

Evans J. , “The Uneven Playing Field of the Dialogue on Patenting,” in Chapman A. , ed., Perspectives on Gene Patenting (Washington, D.C.: American Association for the Advancement of Science, 1999): At 57–74.

Marshall E. , “Legal Fights over Patents on Life,” Science, 294 (1999): 2067–68.